Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $27.9 million.

  • Pliant Therapeutics' Cash from Investing Activities fell 981.59% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $171.7 million, marking a year-over-year increase of 2893.81%. This contributed to the annual value of $140.3 million for FY2024, which is 21049.35% up from last year.
  • According to the latest figures from Q3 2025, Pliant Therapeutics' Cash from Investing Activities is $27.9 million, which was down 981.59% from $35.5 million recorded in Q2 2025.
  • Over the past 5 years, Pliant Therapeutics' Cash from Investing Activities peaked at $69.1 million during Q1 2025, and registered a low of -$178.3 million during Q3 2022.
  • Over the past 5 years, Pliant Therapeutics' median Cash from Investing Activities value was $25.8 million (recorded in 2021), while the average stood at $3.6 million.
  • Per our database at Business Quant, Pliant Therapeutics' Cash from Investing Activities plummeted by 1147870.67% in 2023 and then skyrocketed by 23159.22% in 2025.
  • Quarter analysis of 5 years shows Pliant Therapeutics' Cash from Investing Activities stood at $25.8 million in 2021, then dropped by 22.34% to $20.0 million in 2022, then soared by 59.43% to $31.9 million in 2023, then rose by 22.59% to $39.1 million in 2024, then dropped by 28.65% to $27.9 million in 2025.
  • Its Cash from Investing Activities was $27.9 million in Q3 2025, compared to $35.5 million in Q2 2025 and $69.1 million in Q1 2025.